Use Kerendia To Stop Diabetic Kidney Disease!

TL;DR

Carendia is a newly approved medication that can slow the progression of diabetic kidney disease, lower the risk of end-stage kidney disease, and reduce the risk of heart disease.

Transcript

today we are talking about a new medication designed to save your kidneys if you have diabetic kidney disease hi i'm dr ahmed ergen i'm an integrative endocrinologist specializing in endocrinology i use both natural homeopathic remedies and pharmaceuticals only if the benefits is much greater than the risks so today i will talk about the benefits a... Read More

Key Insights

• ✋ Approximately 40 million adults in the US have chronic kidney disease, with diabetics being at higher risk.
• 👍 Carendia is the first medication specifically approved to treat chronic kidney disease related to diabetes.
• ❤️‍🩹 Carendia slows the progression of chronic kidney disease, lowers the risk of end-stage kidney disease, reduces the risk of heart disease and heart attacks, and can lower the chances of hospitalization due to heart failure.
• 🥰 Carendia works by reducing the harmful effects of aldosterone, which can cause kidney damage and heart issues.
• ✋ Symptoms of chronic kidney disease may not be apparent until later stages, but changes in urine production, fatigue, high blood pressure, and diabetes-related complications can indicate its presence.
• ✋ Carendia may have potential side effects, including high potassium levels, and may interact with grapefruit, CYP3A inhibitors, and CYP3A inducers.
• 🆘 Insurance coverage for Carendia is still limited, but vouchers and coupons may be available to help with the cost.

Questions & Answers

Q: How does chronic kidney disease affect diabetics?

Chronic kidney disease is a progressive disease that damages the kidneys, and diabetics are at a higher risk of developing it due to long-term elevated blood sugar levels.

Q: What are the symptoms of chronic kidney disease?

Symptoms may not be apparent until later stages, but changes in urine production, shortness of breath, swelling in the legs and ankles, fatigue, high blood pressure, and diabetes-related complications can indicate the presence of chronic kidney disease.

Q: How does Carendia work to prevent chronic kidney disease complications?

Carendia is a mineralocorticoid receptor antagonist that reduces the harmful effects of aldosterone. By minimizing the effects of aldosterone on the kidneys, heart, and blood vessels, Carendia helps prevent further kidney damage, heart problems, and complications associated with chronic kidney disease.

Q: What are the potential side effects and drug interactions of Carendia?

The most common side effect is high potassium levels, so monitoring potassium levels is important. Carendia may interact with grapefruit, CYP3A inhibitors, and CYP3A inducers, so caution and consultation with a healthcare professional is advised.

Key Insights:

• Approximately 40 million adults in the US have chronic kidney disease, with diabetics being at higher risk.
• Carendia is the first medication specifically approved to treat chronic kidney disease related to diabetes.
• Carendia slows the progression of chronic kidney disease, lowers the risk of end-stage kidney disease, reduces the risk of heart disease and heart attacks, and can lower the chances of hospitalization due to heart failure.
• Carendia works by reducing the harmful effects of aldosterone, which can cause kidney damage and heart issues.
• Symptoms of chronic kidney disease may not be apparent until later stages, but changes in urine production, fatigue, high blood pressure, and diabetes-related complications can indicate its presence.
• Carendia may have potential side effects, including high potassium levels, and may interact with grapefruit, CYP3A inhibitors, and CYP3A inducers.
• Insurance coverage for Carendia is still limited, but vouchers and coupons may be available to help with the cost.
• Discussing Carendia with a healthcare professional is important to determine eligibility and monitor potential side effects and drug interactions.

Summary & Key Takeaways

• Kidneys are crucial organs that clean our blood, regulate blood pressure, and produce red blood cells. However, chronic kidney disease affects approximately 40 million adults in the US, with diabetics being at a higher risk.

• Carendia is the first FDA-approved medication specifically designed for chronic kidney disease related to diabetes. It works by reducing the harmful effects of aldosterone, a hormone that can cause kidney damage and heart issues.

• The medication can slow down the progression of chronic kidney disease, lower the risk of end-stage kidney disease, reduce the risk of heart disease and heart attacks, and even decrease hospitalization due to heart failure in diabetic patients.